Registry Experience at the Washington Hospital Center, DES - Xience V
- Conditions
- Coronary Artery Disease
- Registration Number
- NCT01003977
- Lead Sponsor
- Rebecca Torguson
- Brief Summary
Single center registry of patients who have received a Xience V everolimus-eluting stent at the Washington Hospital Center, with the primary objective to assess clinical success and safety at 30 days, 6 months and 1 year post-implantation.
- Detailed Description
Interventional cardiology was revolutionized by the invention of stents, initially with the bare-metal stents (BMS) and recently with the drug-eluting stents (DES). The everolimus eluting, Xience V stents have shown very promising results in randomized clinical trials, demonstrating a reduction of clinical and angiographic restenosis in comparison to BMS, and comparable clinically-driven target lesion revascularization rates in comparison with sirolimus-eluting stents. While registry data is available from outside of the United States, it will be important to collect "real-world" data regarding the stent usage and outcomes in the United States. In this study we propose to follow patients who received at least one Xience V® Stent for at least 1 year post initial stent implantation.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 6069
- Patients, male or female, >18 years of age
- Patients who received at least one Xience V drug-eluting stent at the Washington Hospital Center
- Patients who received another type of DES (other than Xience V) or a bare metal stent at the time of initial Xience V stent implantation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of Major Adverse Cardiac Events (MACE) post Xience V implantation Follow Up
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Washington Hospital Center
🇺🇸Washington, District of Columbia, United States